Sen. Kamala Harris (D-CA) is the latest potential 2020 presidential candidate to support marijuana legalization.
The California senator announced on Thursday that she is signing onto a far-reaching bill to end the federal prohibition of cannabis, The Marijuana Justice Act, introduced last year by Sen. Cory Booker (D-NJ).
“It’s the smart thing to do. It’s the right thing to do,” she said in an interview with NowThis. “And I know this as a former prosecutor, I know this as a senator, and I know it when I just look at what we want as a country and where we need to be instead of where we’ve been.”
Making marijuana legal at the federal level is the smart thing to do and it’s the right thing to do. Today, I’m announcing my support for @CoryBooker’s Marijuana Justice Act. pic.twitter.com/cOh3SjMaOW
Harris has now joined the ranks of other potential 2020 Democratic presidential contenders who’ve endorsed the legislation, including Sens. Bernie Sanders (I-VT) and Kirsten Gillibrand(D-NY). Booker himself is believed to be exploring a run for the party’s nomination as well.
Harris has faced criticism from legalization advocates for recently making public statements about the importance of federal cannabis reform, while until now declining to introduce or co-sponsor legislation that would actually accomplish that.
The Marijuana Justice Act would remove marijuana from the Controlled Substances Act so that states could legalize without federal interference, and would withhold funding from states that maintain criminalization and continue to have racially disproportionate arrest and incarceration rates for cannabis.
The legislation would also direct federal courts to expunge prior marijuana convictions and allow people punished under disproportionately enforced cannabis laws to file civil lawsuits against those states.
Money withheld from states with discriminatory marijuana policies would be used to fund job training and libraries.
It’s time to not only legalize marijuana, but to expunge the records of those who have been carrying the burdens of past convictions for too long.
The Thursday announcement about signing onto the bill represents a stark reversal for Harris who, as California attorney general in 2014, simply laughed in a reporter’s face in response to a question about her position on marijuana.
Nevertheless, Harris’s move serves as yet another example of the rapid evolution in U.S. marijuana politics, with a growing number of high-profile lawmakers apparently recognizing the political capital of taking a pro-legalization approach to federal marijuana policy.
Hundreds of marijuana reform bills have been filed in Congress in recent years, but none have ever been given a vote, until now.
In an historical first, a House committee approved cannabis law reform legislation on Tuesday. While legalization supporters have previously scored victories in the form of amendments attached to larger legislation, none of their standalone bills have ever advanced before.
Though the current proposal is fairly limited in scope — it would encourage the U.S. Department of Veterans Affairs to conduct research on marijuana’s medical benefits — it comes at a time of unprecedented bipartisan support for cannabis reform and likely signals more action to come on Capitol Hill.
“The tide is turning on cannabis, and today’s vote is the latest example,” Congressman Earl Blumenauer (D-OR) told Marijuana Moment. “We still have a long way to go, but we are one step closer to helping our veterans get the care they want and deserve. Now is our moment. Now is the time to redouble our efforts.”
Filed by Veterans’ Affairs Committee GOP Chairman Phil Roe of Tennessee and Congressman Tim Walz of Minnesota, the top Democrat on the committee, along with 52 other cosponsors, the bill would encourage the U.S. Department of Veterans Affairs (VA) to “conduct and support research relating to the efficacy and safety” of medical cannabis “on the health outcomes of covered veterans diagnosed with chronic pain, post-traumatic stress disorder, and other conditions.”
The committee approved the bill by a voice vote after a brief discussion.
Sens. Jon Tester (D-MT) and Dan Sullivan (R-AK) introduced a companion bill in the Senate on Monday.
Under the bill as introduced, VA research would be conducted on whole plant marijuana as well as extracts, and involve “at least three different strains of cannabis with significant variants in phenotypic traits and various ratios of tetrahydrocannabinol and cannabidiol in chemical composition.”
Studies would examine “varying methods of cannabis delivery, including topical application, combustible and noncombustible inhalation, and ingestion.”
The legislation would require VA to preserve all data collected from the studies and issue a report to Congress within 180 days that includes a plan for implementation of research. The department would also have to send updates no less than annually for a period of five years.
Separately, the U.S. House Appropriations Committee called on VA to expand medical cannabis research on Tuesday. In the report attached to legislation to fund VA for Fiscal Year 2019, the panel wrote:
“Cannabis research.—The Committee recognizes that continued focus on the discovery of treatment alternatives for veterans diagnosed with various conditions such as chronic pain and PTSD are essential to reducing the number of veteran suicides. For this reason, the Committee urges VA to utilize funds, in an amount deemed appropriate by the Secretary, to prioritize investments in research on the efficacy and safety of cannabis usage among the veteran population for medicinal purposes. The Committee also requests a report, within 180 days after the enactment of this Act, by the Secretary containing a detailed plan on how the Department expects to pursue this research. The Committee also urges VA to ensure any research conducted or supported by VA on cannabis therapy is preserved in a manner that will facilitate further research.”
While VA is already allowed to participate in cannabis research under current law, its leadership has been reluctant. Former Sec. David Shulkin, for example, repeatedly claimed in public remarks that Congress needs to act before the department can refer veterans to cannabis studies.
“While this bill is certainly modest in its immediate impact, we believe that it is a necessary first step toward building bipartisan support for broader cannabis reform legislation in Congress,” the Veterans Cannabis Coalition said in a statement. “Hundreds of thousands of veterans, like the millions of other Americans who have medicated with cannabis, have experienced profound and sustained relief or elimination of underlying conditions. Many of those conditions–prominently traumatic brain injuries (TBI), post-traumatic stress disorder (PTSD), and chronic pain–are poorly managed with current medication models, with health providers offering few or no alternatives to powerful pharmaceuticals like opioids, stimulants, and tranquilizers to patients.”
Legalization activists say that the research bill doesn’t go nearly far enough. They want Congress to force the VA to begin letting its doctors issue recommendations for military veterans in states where it is legal.
“The VA has been instrumental in cutting edge research to improve the lives of those who serve our country,” Justin Strekal, political director for NORML, told Marijuana Moment. “With nearly 1 in 4 veterans reporting that they consume cannabis to alleviate their ailments, it is absolutely imperative that the VA reform their policies to both conduct research and allow VA doctors to recommend therapeutic cannabis when they see fit.”
Before approving the research bill, the Veterans Affairs Committee adopted an amendment that alters some of its reporting requirements and other provisions.
See the original article published on Marijuana Moment below:
Maine lawmakers have overridden a gubernatorial veto of a bill to implement a regulatory system for recreational marijuana in the state.
On Wednesday, the House voted 109-39 and, shortly thereafter, the Senate voted 28-6, thwarting the latest attempt by Gov. Paul LePage (R) to block a voter-approved cannabis ballot initiative from taking effect.
2-19, LD 1719, IMPLMNT A REGULATORY STRUCTURE FOR ADULT USE MARIJUANA, RECONSIDERATION – VETO, Yea 109 Nay 39
“There are parts of the bill that we liked and some parts that we didn’t like,” David Boyer, Maine political director for the Marijuana Policy Project, told Marijuana Moment in an interview. “Ultimately we’re glad that the legislature is moving towards a regulated marketplace. We are approaching two years since Maine voters passed this, and adults in Maine deserve a place to purchase marijuana legally.”
LePage is known nationally for his anti-legalization stance. He generated headlines around the United States ahead of the state’s November 2016 election for his fear-mongering and often inaccurate public statements about the implications of cannabis reform.
But a slim majority of Maine voters opted to legalize recreational marijuana anyway, in spite of the governor’s protests.
A year later, in November 2017, LePage vetoed an earlier version of a bill to regulate recreational marijuana in Maine. But lawmakers did not reach the two-thirds majority in both the state House and Senate that are required to override a governor’s veto, and so went back to the table to craft a new plan that could earn broader support.
In his more recent veto letter, from last month, LePage argued that federal law prohibits marijuana and that the regulatory proposal failed to “adequately address the failings of the [state’s] medical marijuana program.” He also voiced concerns that recreational legalization would lead to higher traffic fatalities.
(In March, a report from the National Bureau of Economic Research determined that “states that legalized marijuana have not experienced significantly different rates of marijuana- or alcohol-related traffic fatalities relative to their synthetic controls.”)
“We hope the governor will stop dragging his feet and implement this bill in a timely manner,” Boyer said, adding that he is disappointed lawmakers removed social use provisions from the bill.
Asked to comment on the legislature’s override, LePage spokesperson Peter Steele referred Marijuana Moment to the governor’s veto letter. “We are not commenting further,” he said.
See the original article published by Marijuana Moment below: